AP
PGNX

AHL Partners’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

AHL Partners’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19,919
Closed -$147K – 1412
2017
Q3 		$147K Buy
+19,919
New +$147K ﹤0.01% 1212